China's drug regulator has approved the country's first mixed-vaccine trial, a company involved in the study said, as the rapid spread of the Delta variant raises concern about the efficacy of domestically produced jabs.
Aug 11, 2021
0
106
Moderna said Thursday that protection from its COVID-19 vaccine remained strong for at least six months, and the variant-specific boosters shot it is testing generated a "robust" antibody response to Delta.
Aug 5, 2021
0
4
Lyme disease has become an insidious epidemic in the United States. Caused by bacteria transmitted through the bite of an infected tick, it can lead to heart problems, meningitis or arthritis if left untreated. It is the ...
Aug 4, 2021
0
198
Over a year into the pandemic, questions around immune responses after COVID continue to confound.
Aug 2, 2021
0
133
Imagine a COVID-19 vaccine that came as a pill: no needles, no medical professionals required to administer it, potentially delivered directly to people's homes.
Aug 1, 2021
0
121
Russia was the first country to register a COVID vaccine, with its health ministry giving emergency approval to the Sputnik V vaccine in August 2020.
Jul 28, 2021
0
239
Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
Jul 27, 2021
0
4
Just one age group remains when it comes to qualifying for a COVID-19 vaccine: young children.
Jul 26, 2021
0
3
Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.
Jul 26, 2021
0
15
TB is one of the oldest infectious diseases in recorded history. Most of the people who are ill with TB live in low- and middle-income countries where this disease is one of the leading causes of death. This is particularly ...
Jul 22, 2021
0
1
